poly(ethylene glycol)-b-(poly(ethylenediamine glutamate)-g-poly(lysine))

Also Known As:

PEG-b-(PELG-g-PLL)

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Alcohols: 595
  - Glycols: 38
    - Ethylene Glycols: 8
      - Polyethylene Glycols: 3865
        poly(ethylene glycol)-b-(poly(ethylenediamine glutamate)-g-poly(lysine)): 2
Macromolecular Substances: 97
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - poly(ethylene glycol)-b-(poly(ethylenediamine glutamate)-g-poly(lysine)): 2
Biomedical and Dental Materials
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - poly(ethylene glycol)-b-(poly(ethylenediamine glutamate)-g-poly(lysine)): 2
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - Polyethylene Glycols: 3865
        poly(ethylene glycol)-b-(poly(ethylenediamine glutamate)-g-poly(lysine)): 2
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Polylysine: 237
    - poly(ethylene glycol)-b-(poly(ethylenediamine glutamate)-g-poly(lysine)): 2
- Amino Acids: 30675
  - Basic Amino Acids: 178
    - Lysine: 6737
      - Polylysine: 237
        poly(ethylene glycol)-b-(poly(ethylenediamine glutamate)-g-poly(lysine)): 2
  - Diamino Amino Acids: 101
    - Lysine: 6737
      - Polylysine: 237
        poly(ethylene glycol)-b-(poly(ethylenediamine glutamate)-g-poly(lysine)): 2

Experts

1.	Liu, Daojun: 2 articles (01/2017 - 01/2016)
2.	Tong, Fei: 2 articles (01/2017 - 01/2016)
3.	Gu, Huan: 1 article (01/2017)
4.	Gu, Jiang: 1 article (01/2017)
5.	Hu, Bo: 1 article (01/2017)
6.	Xu, Guangtao: 1 article (01/2017)
7.	Yu, Xiaojun: 1 article (01/2017)
8.	Zheng, Yongxia: 1 article (01/2017)
9.	Li, Xin: 1 article (01/2016)
10.	Tang, Xiangyuan: 1 article (01/2016)

Related Diseases

1.	Ischemia 01/01/2017 - "Sprague Dawley rats were preconditioned with free TNF-α or TNF-α/PEG-b-(PELG-g-PLL) polyplexes and then subjected to 2 hours ischemia and 22 hours reperfusion. " 01/01/2016 - "The aim of this study was to observe the therapeutic effect of insulin-loaded linear poly(ethylene glycol)-brush-like poly(l-lysine) block copolymer poly(ethylene glycol)-b-(poly(ethylenediamine l-glutamate)-g-poly(l-lysine)) (PEG-b-(PELG-g-PLL) on renal ischemia/reperfusion-induced lung injury through downregulating hypoxia-inducible factor (HIF) as compared to free insulin. "
2.	Lung Injury 01/01/2016 - "The aim of this study was to observe the therapeutic effect of insulin-loaded linear poly(ethylene glycol)-brush-like poly(l-lysine) block copolymer poly(ethylene glycol)-b-(poly(ethylenediamine l-glutamate)-g-poly(l-lysine)) (PEG-b-(PELG-g-PLL) on renal ischemia/reperfusion-induced lung injury through downregulating hypoxia-inducible factor (HIF) as compared to free insulin. "
3.	Hypoxia (Hypoxemia) 01/01/2016 - "The aim of this study was to observe the therapeutic effect of insulin-loaded linear poly(ethylene glycol)-brush-like poly(l-lysine) block copolymer poly(ethylene glycol)-b-(poly(ethylenediamine l-glutamate)-g-poly(l-lysine)) (PEG-b-(PELG-g-PLL) on renal ischemia/reperfusion-induced lung injury through downregulating hypoxia-inducible factor (HIF) as compared to free insulin. "
4.	Reperfusion Injury 01/01/2017 - "PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications."
5.	Brain Ischemia (Cerebral Ischemia) 01/01/2017 - "PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications."

Related Drugs and Biologics

1.	Therapeutic Uses
2.	Ethylene Glycol (Monoethylene Glycol)
3.	Glutamic Acid (Glutamate)
4.	Lysine (L-Lysine)
5.	Insulin (Novolin)
6.	ethylenediamine (ethylenediamine dihydroiodide)